Cytosorbents (CTSO) Total Non-Current Liabilities (2010 - 2017)

Cytosorbents has reported Total Non-Current Liabilities for 6 years, with the latest figure at $13.1 million in Q2 2017.

• For the quarter ending Q2 2017, Total Non-Current Liabilities rose 87.33% year-over-year to $13.1 million; the trailing twelve-month figure through Jun 2017 stood at $13.1 million (up 87.33% YoY), and the FY2016 full-year result was $6.5 million, up 364.95% from the prior year.
• Total Non-Current Liabilities for Q2 2017 stood at $13.1 million, up from $8.2 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $13.1 million in Q2 2017, with the low at -$1.5 million in Q4 2014.
• Historically, Total Non-Current Liabilities has averaged $5.5 million across 4 years, with a median of $6.8 million in 2016.
• The largest YoY upside for Total Non-Current Liabilities was 402.59% in 2017 against a maximum downside of 87.33% in 2017.
• Cytosorbents' Total Non-Current Liabilities stood at -$1.5 million in 2014, then jumped by 196.59% to $1.4 million in 2015, then surged by 364.95% to $6.5 million in 2016, then soared by 100.53% to $13.1 million in 2017.
• The last three Total Non-Current Liabilities figures came in at $13.1 million (Q2 2017), $8.2 million (Q1 2017), and $6.5 million (Q4 2016), per Business Quant data.